Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (3): 623-627. doi: 10.19723/j.issn.1671-167X.2021.03.031

Previous Articles     Next Articles

Utilizing social media data in post-market safety surveillance

YANG Yu1,WANG Sheng-feng2,ZHAN Si-yan2,Δ()   

  1. 1. National Institute of Health Data Science, Peking University, Beijing 100191, China
    2. Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, Chian
  • Received:2020-12-10 Online:2021-06-18 Published:2021-06-16
  • Contact: Si-yan ZHAN E-mail:siyan-zhan@bjmu.edu.cn
  • Supported by:
    National Key Research and Development Program of China(2018AAA0102100)

Abstract:

Post-marketing surveillance is the principal means to ensure drug use safety. The spontaneous report is the essential method of post-marketing surveillance for drug safety. Often most spontaneous reports come from medical staff and sometimes come from patients who use the drug. The posts published by individuals on social media platforms that contain drugs and related adverse reaction content have gradually been seen as a new data source similar to spontaneous reports from drug users in recent years. Those user-generated posts potentially provide researchers and regulators with new opportunities to conduct post-marketing surveillance for drug safety from patients’ perspectives mostly rather than medical professionals and can afford the possibility theoretically to discover drug-related safety issues earlier than traditional methods. Social media data as a new data source for safety signal detection and signal reinforcement have the unique advantages, such as population coverage,type of drugs, type of adverse reactions, data timeliness and quantity. Most of the social media data used in post-marketing surveillance research for drug safety are still text data in English, and even multiple languages are used by different people worldwide on several social media platforms. Unfortunately, there is still a controversy in the academic circles whether social media data can be used as reliable data sources for routine post-marketing surveillance for drug safety. A couple of obstacles of data, methods and ethics must be overcome before leveraging social media data for post-marketing surveillance. The number of Chinese social media users is large, and the social media data in the Chinese language is rapidly snowballing, which can be employed as the potential data source for post-marketing surveillance for drug safety. However, due to the Chinese language’s specific characteristics, the text’s diversity is different from the English text, and there is not enough accepted corpus in medical scenarios. Besides, the lack of domestic laws and regulations on privacy and security protection of social media data poses more challenges for applying Chinese social media data for post-market surveillance. The significance of social media data to post-marketing surveillance for drug safety is undoubtedly significant. It will be an essential development direction for future research to overcome the challenges of using social media data by developing new technologies and establishing new mechanisms.

Key words: Drug safety, Post-marketing surveillance, Social media

CLC Number: 

  • R9
[1] 崔燕宁. 药物安全与药物警戒[M]. 北京: 人民卫生出版社, 2014: 1-2.
[2] Lester J, Neyarapally GA, Lipowski E, et al. Evaluation of FDA safety-related drug label changes in 2010[J]. Pharmacoepidemiol Drug Saf, 2013,22(3):302-305.
doi: 10.1002/pds.3395 pmid: 23280652
[3] Al DR, Stacey D, Kohen D, et al. Factors affecting patient reporting of adverse drug reactions: a systematic review[J]. Br J Clin Pharmacol, 2017,83(4):875-883.
doi: 10.1111/bcp.v83.4
[4] 丁呈怡, 詹思延. 药品使用者自发报告的价值与促进策略[J]. 药物流行病学杂志, 2016,25(1):55-58.
[5] 赵云泽, 张竞文, 谢文静, 等. “社会化媒体”还是“社交媒体”?一组至关重要的概念的翻译和辨析[J]. 新闻记者, 2015(6):63-66.
[6] Ghosh R, Lewis D. Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media[J]. Expert Opin Drug Saf, 2015,14(12):1845-1853.
doi: 10.1517/14740338.2015.1096342
[7] Digital use around the world in July 2020: we are social[EB/OL]. (2020-09-06)[2020-11-20]. https://wearesocial.com/blog/2020/07/digital-use-around-the-world-in-july-2020#.
[8] TenBarge AM, Riggins JL. Responding to unsolicited medical requests from health care professionals on pharmaceutical industry-owned social media sites: three pilot studies[J]. J Med Internet Res, 2018,20(10):e285.
doi: 10.2196/jmir.9643
[9] van Stekelenborg J, Ellenius J, Maskell S, et al. Recommendations for the use of social media in pharmacovigilance: lessons from IMI WEB-RADR[J]. Drug Saf, 2019,42(12):1393-1407.
doi: 10.1007/s40264-019-00858-7 pmid: 31446567
[10] Pierce C E, Bouri K, Pamer C, et al. Evaluation of Facebook and Twitter monitoring to detect safety signals for medical products: an analysis of recent FDA safety alerts[J]. Drug Saf, 2017,40(4):317-331.
doi: 10.1007/s40264-016-0491-0
[11] Sarker A, Ginn R, Nikfarjam A, et al. Utilizing social media data for pharmacovigilance: a review[J]. J Biomed Inform, 2015,54:202-212.
doi: 10.1016/j.jbi.2015.02.004 pmid: 25720841
[12] Correia R, Li L, Rocha L. Monitoring potential drug interactions and reactions via network analysis of Instagram user timelines[J]. Pac Symp Biocomput, 2016,21:492-503.
[13] Nikfarjam A, Ransohoff JD, Callahan A, et al. Early detection of adverse drug reactions in social health networks: a natural language processing pipeline for signal detection[J]. JMIR Public Health Surveill, 2019,5(2):e11264.
doi: 10.2196/11264
[14] Karapetiantz P, Bellet F, Audeh B, et al. Descriptions of adverse drug reactions are less informative in forums than in the French pharmacovigilance database but provide more unexpected reactions[J]. Front Pharmacol, 2018,9:439.
doi: 10.3389/fphar.2018.00439
[15] Karapetiantz P, Audeh B, Lillo-Le LA, et al. Signal detection for baclofen in web forums: a preliminary study[J]. Stud Health Technol Inform, 2018,247:421-425.
pmid: 29677995
[16] Kurzinger ML, Schuck S, Texier N, et al. Web-based signal detection using medical forums data in France: comparative analysis[J]. J Med Internet Res, 2018,20(11):e10466.
doi: 10.2196/10466
[17] Leaman R, Wojtulewicz L, Sullivan R, et al. Towards inter-netage pharmacovigilance: extracting adverse drug reactions from user posts to health-related social networks[C]. Uppsala, Sweden: Association for Computational Linguistics, 2010.
[18] Tricco AC, Zarin W, Lillie E, et al. Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review[J]. BMC Med Inform Decis Mak, 2018,18(1):38.
doi: 10.1186/s12911-018-0621-y
[19] Powell GE, Seifert HA, Reblin T, et al. Social media listening for routine post-marketing safety surveillance[J]. Drug Saf, 2016,39(5):443-454.
doi: 10.1007/s40264-015-0385-6
[20] Freifeld CC. Digital pharmacovigilance: the medwatcher system for monitoring adverse events through automated processing of internet social media and crowdsourcing[D]. Boston: Boston University, 2014.
[21] Blumenthal KG, Topaz M, Zhou L, et al. Mining social media data to assess the risk of skin and soft tissue infections from allergen immunotherapy[J]. J Allergy Clin Immunol, 2019,144(1):129-134.
doi: 10.1016/j.jaci.2019.01.029
[22] Duval FV, Silva F. Mining in Twitter for adverse events from malaria drugs: the case of doxycycline[J]. Cad Saude Publica, 2019,35(5):e33417.
[23] Convertino I, Ferraro S, Blandizzi C, et al. The usefulness of listening social media for pharmacovigilance purposes: a systematic review[J]. Expert Opin Drug Saf, 2018,17(11):1081-1093.
doi: 10.1080/14740338.2018.1531847 pmid: 30285501
[24] Lardon J, Bellet F, Aboukhamis R, et al. Evaluating Twitter as a complementary data source for pharmacovigilance[J]. Expert Opin Drug Saf, 2018,17(8):763-774.
doi: 10.1080/14740338.2018.1499724
[25] Li Y, Jimeno YA, Xiao C. Combining social media and FDA adverse event reporting system to detect adverse drug reactions[J]. Drug Saf, 2020,43(9):893-903.
doi: 10.1007/s40264-020-00943-2
[26] Bousquet C, Dahamna B, Guillemin-Lanne S, et al. The adverse drug reactions from patient reports in social media project: five major challenges to overcome to operationalize analysis and efficiently support pharmacovigilance process[J]. JMIR Res Protoc, 2017,6(9):e179.
[27] Hoang T, Liu J, Pratt N, et al. Authenticity and credibility aware detection of adverse drug events from social media[J]. Int J Med Inform, 2018,120:101-115.
doi: S1386-5056(18)30326-5 pmid: 30409335
[28] Sloane R, Osanlou O, Lewis D, et al. Social media and pharmacovigilance: a review of the opportunities and challenges[J]. Br J Clin Pharmacol, 2015,80(4):910-920.
doi: 10.1111/bcp.12717
[29] Audeh B, Bellet F, Beyens MN, et al. Use of social media for pharmacovigilance activities: key findings and recommendations from the Vigi4Med project[J]. Drug Saf, 2020,43(9):835-851.
doi: 10.1007/s40264-020-00951-2
[30] 魏巍. 药物不良反应知识发现与利用模型研究[D]. 武汉大学, 2017.
[31] Wong A, Plasek JM, Montecalvo SP, et al. Natural language processing and its implications for the future of medication safety: a narrative review of recent advances and challenges[J]. Pharmacotherapy, 2018,38(8):822-841.
doi: 10.1002/phar.2018.38.issue-8
[32] Meng X, Ganoe CH, Sieberg RT, et al. Self-supervised contextual language representation of radiology reports to improve the identification of communication urgency[J]. AMIA Jt Summits Transl Sci Proc, 2020,2020:413-421.
[33] Pariente A, Gregoire F, Fourrier-Reglat A, et al. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias[J]. Drug Saf, 2007,30(10):891-898.
doi: 10.2165/00002018-200730100-00007
[34] Rees S, Mian S, Grabowski N. Using social media in safety signal management: is it reliable?[J]. Ther Adv Drug Saf, 2018,9(10):591-599.
doi: 10.1177/2042098618789596
[35] Golder S, Scantlebury A, Christmas H. Understanding public attitudes toward researchers using social media for detecting and monitoring adverse events data: multi methods study[J]. J Med Internet Res, 2019,21(8):e7081.
doi: 10.2196/jmir.7081
[1] CHENG Yin-chu, PAN Yong-ping, ZHANG Yang,PAN Yu-ting, DING Cheng-yi, CAO Yu, ZHUO Lin, FANG Ren-fei, GAO Ai-yu, GUO Jing, LI Ai-jun, FU Qiang, MA Jun, ZHAN Si-yan. Investigation of the cognition and behavior on drug safety in Beijing middle school students [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 1038-1043.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .